London, UK - 08 November 2018 - NetScientific plc ("NetScientific", AIM:NSCI), the transatlantic healthcare IP commercialisation group, announces that its US-based portfolio company, Vortex ...
MENLO PARK, Calif.--(BUSINESS WIRE)--Vortex Biosciences previewed the VTX-1, a fully automated system for the efficient enrichment of intact circulating tumor cells (CTCs) from whole blood, at the ...
Vortex Biosciences Announces Publications Supportive of its Circulating Tumour Cell Technology London, UK - March 31st 2017 - NetScientific plc (AIM:NSCI), the transatlantic healthcare IP ...
Vortex Biosciences previewed the VTX-1, a fully automated system for the efficient enrichment of intact circulating tumor cells (CTCs) from whole blood, at the American Association for Cancer Research ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback